Page 3 - Berkeley Biologics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elutia Shares Jump 44% After Selling Orthobiologics Business

By Ben Glickman Shares of Elutia jumped after the company said it would sell its orthobiologics business for up to $35 million in cash. The stock was up 44%.

Ben glickmanBerkeley biologicsSilver springArticle normalFinancial performanceShare price movement disruptionsOwnership changesAcquisitions mergers shareholdingsCorporate actionsCorporate industrial newsContent typesFactiva filtersC amp ampe exclusion filterC amp ampe industry news filterShare price movementIndustrial news

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Berkeley biologicsDrug administrationLemaitre vascularSecurities exchangeCompany orthobiologicsGroup ltdElutia incExchange commissionMizuho securities united statesSurgalign holdings incTransaction reflects increasing strategic focusProprietary drug eluting biomatrix platformBrandy millsChief executive officerSecurities actSecurities exchange act

Elutia (ELUT) Sells Orthobiologics Business Unit for Up to $35M Cash

Elutia (ELUT) Sells Orthobiologics Business Unit for Up to $35M Cash
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Berkeley biologicsMizuho securities united statesDrug administrationGroup ltdElutia incCompany orthobiologicsBrandy millsChief executive officer